Fluoroscopy, also known as motion X-ray, produces mobile images of the body’s parts and organs. In fluoroscopy procedures, X-rays are passed through the body and received by an image intensifier. Image intensifier converts the X-rays into a visible and moving image on a monitor.
Fluoroscopy procedures are used to diagnose diseases and guide physicians during treatment practices. Some fluoroscopy procedures performed as out-patient practices. For instance, upper gastrointestinal series are used to examine the esophagus, small intestine and stomach. Other procedures are performed as hospital procedures or sometimes as inpatient procedures. For instance, cardiac catheterization is used to examine the heart and the coronary arteries that supply blood to the heart muscle.
In addition, fluoroscopy permits the radiologist to visualize the organ system of the patient for the diagnosis of diseases. Radiologist studied patient’s organ systems with the aid of contrast agents. Contrast agents are very necessary for fluoroscopy procedures due to soft tissue require enhancing for the visualization of tissues.
Fluoroscopy instrument is divided into two main types: remote-controlled systems and patient-side control system. Remote-controlled fluoroscopy systems are designed with the X-ray tubes over the table and remote operation. However, patient-side controlled fluoroscopy systems are designed with table-side controls for examinations where it is required to remain at any side of the patient. This is specifically designed for pediatric patients.
In terms of geographic, North America dominates the global ray fluoroscopy instrument market. This is due to improved healthcare infrastructure in North America. The U.S. represents the largest market for ray fluoroscopy instrument followed by Canada in North America. Germany, France and the U.K. holds major share of ray fluoroscopy instrument market in Europe. However, Asia is expected to show high growth rates in the next five years in global ray fluoroscopy instrument market. This is due to many companies constructing their manufacturing plants in the region. In addition, increasing number of conferences and exhibitions by manufacturing companies to promote ray fluoroscopy instruments is also contributing in the growth of ray fluoroscopy instruments market in the region. Japan, China and India are expected to be the fastest growing ray fluoroscopy instruments markets in Asia.
In recent time, increasing prevalence of diseases, such as cardiovascular diseases and gastrointestinal diseases is key diver of the global ray fluoroscopy instruments market. Improving healthcare infrastructure and innovative applications of fluoroscopy instruments have also fueled the growth of global ray fluoroscopy instruments market. In addition, increasing healthcare spending in developed and developing parts of the world and technological advancement in the fluoroscopy procedures are also supporting in growth of the market. For instance, introduction of small volume and light weight portable ray fluoroscopy instruments offers easier and convenient services to end users.
However, high cost of instruments is key restraint of global ray fluoroscopy instrument market. In addition, lack of skill labor to operate expensive instruments and stringent regulatory standards also hampers the growth of global ray fluoroscopy instrument market. Increasing mergers and collaborations between key players is key trend of the global ray fluoroscopy instrument market.
Some of the major companies operating in the global ray fluoroscopy instrument market are Siemens Healthcare, GE Healthcare, Philips Healthcare and Shanghai Bojin Medical Instrument Co., Ltd.
Key geographies evaluated in this report are:
Key features of this report